CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 224 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,338 | +230.1% | 17,634 | +169.7% | 0.00% | – |
| Q2 2023 | $145,522 | -34.5% | 6,539 | -36.2% | 0.00% | – |
| Q1 2023 | $222,022 | +57.5% | 10,251 | +47.9% | 0.00% | – |
| Q4 2022 | $141,000 | -0.7% | 6,933 | +24.9% | 0.00% | – |
| Q3 2022 | $142,000 | +21.4% | 5,551 | +16.4% | 0.00% | – |
| Q2 2022 | $117,000 | +254.5% | 4,770 | +24.0% | 0.00% | – |
| Q1 2022 | $33,000 | -52.9% | 3,847 | +10.4% | 0.00% | – |
| Q4 2021 | $70,000 | -43.5% | 3,485 | -44.2% | 0.00% | – |
| Q3 2021 | $124,000 | -11.4% | 6,242 | -1.0% | 0.00% | – |
| Q2 2021 | $140,000 | -51.0% | 6,303 | -46.1% | 0.00% | -100.0% |
| Q1 2021 | $286,000 | -6.5% | 11,698 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $306,000 | +1510.5% | 11,722 | +922.9% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 1,146 | +27.6% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 898 | -20.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 1,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |